Nancy Khardori, MD, PhD, FACP, FIDSA
Department of Internal Medicine
Division of Infectious Diseases
Professor of Medicine and Microbiology/Immunology
Chief, Division of Infectious Diseases
Director, Infectious Diseases Fellowship
Adjunct Faculty, Section of Infectious Diseases, Department of Medical Specialties, The University of Texas MD Anderson Cancer Center

Please visit the divisional website for complete listing.

Scientific Journals:

1. Khardori, N. Stenotrophomonas maltophilia: Antimicrobial therapy. Antibiotics for Clinicians, Volume 11, 352-354.April-June 2006.
2. El-Azizi, M., Adamski, A. And Khardori, N. Role of biofilms in the management of staphylococcal infections. Antibiotics for Clinicians, Volume 10, 15 – 18, 2006.
3. Klotz, SA, Gaur, NK, Armend RD, Sheppard D, Khardori, N, Edwards, JE, Lipke, PH and El-Azizi, M. Candida albicans AIS proteins mediate aggregation with bacteria and yeast. Medical Mycology 45, 363-270, 2007.
4. Koirala, J., Khardori, N. Infections in burn wounds. Infectious Disease Practice. August – September 2007.
5. Koirala, J., Gandotra, SD., Rao, S., Sangwan, G., Mushtaq, A., Htwe,, TH, Adamski, A., Blessman, D., and Khardori, N. Granulocyte colony-stimulating factor dosing in pegylated interferon alpha-induced neutropenia and its impact on outcome of anti-HIV therapy. Journal of Viral Hepatitis, 14, 782-787, 2007.
6. Revilla FJ, Rafael de la Cruz, R., Khardori, N and Espay, AJ. Oculomasticatory myorhythmia: Pathognomonic phenomenology of Whipple’s Disease. Neurology 2008; 70 25 – 27; DOI” 10.1212/01.wnl.0000287142.16160.Of; http://www.neurology.org/cgi/content/full/70/6/e25
7. Koirala, J., Adamski, A., Koch, L. Stueber, D., El-Azizi, M., Ghasseni, M., Novak, R.M. and Khardori N., Interferon-gamma receptors in HIV-1 infection, AIDS Research and Human Retroviruses, Vol. 24(8)July, 2008.
8. Ahmed, M.S., Reid, E. and Khardori, ,N. Respiratory infections in diabetes: Reviewing the risks and challenges. J Respir Dis. 29(7):285-293, 2008.

Book Chapters

1. Khardori, N. Editor – Bioterrorism and Bioterrorism Preparedness – Medicine - Public Health - Policy. Wiley-VCH Publishers, Weinheim, Germany, February 2006.
2. Khardori, N. Potential Agents of Bioterrorism – Historical Perspective and an Overview. In Bioterrorism Preparedness –– Medicine - Public Health - Policy. Wiley-VCH Publishers, Weinheim, Germany, February 2006.
3. Khardori, N. Bioterrorism Preparedness – Historical Perspective and an Overview: Bioterrorism Preparedness – Medicine - Public Health - Policy. Wiley-VCH Publishers, Weinheim, Germany, February 2006.
4. Khardori, N. Anthrax : Bacteriology, Clinical Presentations and Management. In Bioterrorism Preparedness – Medicine - Public Health - Policy. Wiley-VCH Publishers, Weinheim, Germany, February 2006.
5. Khardori N. Editor. Bioterrorism and Bioterrorism Preparedness Infectious Disease Clinics of North America. Elsevier Publishers, June 2006.
6. Khardori, N. Bioterrorism and Bioterrorism Preparedness: A Historical perspective and overview. In Bioterrorism – Infectious Disease Clinics of North America, June 2006.
7. Kyriacou, D.N., Adamski, A. and Khardori, N. Anthrax – From antiquity and obscurity to a front runner in bioterrorism.In Bioterrorism – Infectious Disease Clinics of North America, June 2006.
8. Mushtaq, A., El-Azizi, M. and Khardori, N. Category C potential bioterrorism agents and emerging pathogens.In Bioterrorism – Infectious Disease Clinics of North America, June 2006.
9. Khardori, N. Course Director Emerging Infections – Biological threats and Hidden Epidemics. Southern Illinois University School of Medicine, Springfield, IL, September 2006.
10. Khardori, N., External Reviewer, Ph.D. thesis – Antecedent infections with special references to Campylobacter jejuni and host factors in Guillain-Barre Syndrome Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India, 2006.
11. Khardori, N. Antibiotics: Past, present and future. In Medical Clinics of North America, 90, 1049-1076, November, 2006.
12. Khardori, N and Khardori, R. Editors. Infection in high-risk populations. Infectious Disease Clinics of North America. September 2007.
13. Khardori, N and Khardoroi, R., Infection, Immunity and Hormones/Endocrine interactions. In Infection in high-risk populations. Infectious Disease Clinics of North America. September 2007.
14. Gupta, S., Koirala, J. Khardori, R. and Khardori, N. Infections in Diabetes mellitus and hyperglycemia in Infection in high-risk populations. Infectious Disease Clinics of North America. September 2007.
15. Htwe, TH, Mushtaq, A, Robinson, SB, Rosher, RB and Khardori, N. Infection in high-risk populations. Infectious Disease Clinics of North America. September 2007.
16. Khardori, N. Extra pulmonary TB.National Heartland TB Center, TB Intensive, Chicago, IL, September 2007.
17. Speil, C., Mushtaq, A., Adamski, A. and Khardori, N. Fever of unknown origin. Infectious Disease Clinics of North America, December 2007.
18. Khardori, N. External Reviewer, Ph.D. thesis. A clinic-microbiological study in patients of bronchogenic carcinoma with special reference to aspergillosis. Aligarh Muslim University, Aligarh India, 2008.
19. Khardori, N. Editor, Year Book of Medicine, 2008

Abstracts

1. Gandotra, S., El-Azizi, M. and Khardori, N. In vitro combination of rifampin with other antimicrobial agents against clinical isolates of Stenotrophomonas maltophilia. 17th ECCMID, Nice, France, April 2006.
2. El-Azizi, M., Mushtaq. A. and Khardori, N. Activity of peracetic acid, glutaraldehyde, hydrogen peroxide and Sodium hypochlorite against the biofilm of Multidrug resistant bacteria. 106th General Meeting of ASM., Orlando, Florida, May, 2006.
3. Mushtaq, A., El-Azizi, M. and Khardori, N. Effects of mucin on biofilm formation of methicillin resistant Staphylococcus aureus (MRSA) on endotracheal tube – A major determinant in ventilator associated pneumonia (VAP). 46th Annual ICAAC, San Francisco, CA, September, 2006.
4. Mushtaq, A., El-Azizi, M. and Khardori, N. Role of albumin on colonization of methicillin resistant Staphylococcus aureus (MRSA) on endotracheal tube in vitro - A major determinant in ventilator associated pneumonia (VAP).44th Annual IDSA, Toronto, Ontario, Canada, October, 2006
5. Khardori, N and Kanchanapoom, T. Overview of biological terrorism: potential agents and preparedness. Health and Science Safety Abstracts, 2006.
6. Htwe, TH, Blessman, D., Spain, M., Adamski, A., Mushtaq, A., Koirala, J. and Khardori, N. Management of Pegylated interferon alpha and ribavirin induced neutropenia and thrombocytopenia in patients with chronic hepatitis C. 18th ECCMID, Munich, Germany, April, 2007.
7. Barenfanger, J., Sangwan, G. Speil, C., Htwe, TH, Rethnam, R. Mirza, N, Lawhorn, J., Koirala, J. Mushtaq, A., Henkle, J. and Khardori, N. Limited clinical utility for routine fungal stains on sputa. 107th General Meeting of ASM, Toronto, Canada, May, 2007.
8. Htwe, TH, Koirala, J., Adamski A. and Khardori, N. Interferon-gamma production in response to Mycobacterium avium PPD. 45th Annual IDSA, San Diego, California, October 2007.
9. Suryadevara, A. and Khardori, N. Fever of unknown origin in an immunocompetent host. Downstate Illinois ACP Meeting, Champaign, IL, October, 2007.
10. Faten, S. and Khardori, N. Hisotplasmosis in the immunocompetent. American Federation for Medical Research, Washington, DC, April 2008.
11. Seoudi, A. El-Azizi, M. and Khardori, N. Biodegradation of p. Nitrophenol (PNP) in different ecosystems. 108th General Meeting of ASM, Boston, Massachusetts, June, 2008. 108th General Meeting of ASM, Boston, Massachusetts, June, 2008.
12. Khalifa AT, El-Azizi, M, Khardori, N. Biofilm formation by candida sp on in vitro model of albumin coated silica beads. 108th General Meeting of ASM, Boston, Massachusetts, June, 2008.